News

The Impact Journals news page hosts content about important news articles and press releases from our Journals and Editorial Board Members.

News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Genes & Cancer | Severe Herpesvirus Infection Beats Adult T-cell Leukemia/Lymphoma

News

February 24, 2023
PRESS RELEASE: On January 19, 2023, Genes & Cancer published a new editorial, entitled, “Severe herpesvirus infection beats adult T-cell leukemia/lymphoma.” continue reading »

Oncotarget | Oncogenic Driver FGFR3-TACC3 Requires 5 Coiled-coil Heptads for Activation and Disulfide Bonds for Stability

News

February 23, 2023
PRESS RELEASE: On February 11, 2023, a new research paper was published in Oncotarget, entitled, “Oncogenic driver FGFR3-TACC3 requires five coiled-coil heptads for activation and disulfide bond formation for stability.” continue reading »

Aging | Metformin’s Impact on Aging and Longevity Through DNA Methylation

Aging

February 22, 2023
PRESS RELEASE: A new research paper was published in Aging's Volume 15, Issue 3, entitled, “Metformin use history and genome-wide DNA methylation profile: potential molecular mechanism for aging and longevity.” continue reading »

Oncotarget | Extreme Phenotype Approach Identifies Rare ATR Variants as Potential Male Breast Cancer Susceptibility Alleles

News

February 21, 2023
PRESS RELEASE: On February 7, 2023, a new research paper was published in Oncotarget, entitled, “The ‘extreme phenotype approach’ applied to male breast cancer allows the identification of rare variants of ATR as potential breast cancer susceptibility alleles.” continue reading »

Oncoscience | A Case for Routine Evaluation of HER2 Expression in Ductal Carcinoma In Situ

News

February 17, 2023
PRESS RELEASE: On January 30, 2023, Oncoscience published a new editorial paper: “HER2 expression should be routinely evaluated in DCIS to avoid under or overtreatment!” continue reading »